Who owns PTC THERAPEUTICS INC?
- CUSIP Number: 69366jad3
Tip: Access positions for across all investors
Analyze quarterly positions in Ptc Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Ptc Therapeutics stock
Who bought or sold PTC THERAPEUTICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Franklin Resources | 63M | $59M | 0% | Mar 2024 |
|
Steelhead Partners | 46M | $43B | 0% | Mar 2024 |
|
D. E. Shaw & Co | 33M | $30M | 0% | Mar 2024 |
|
Wolverine Asset Management | 32M | $30M | 0% | Mar 2024 |
|
DeepCurrents Investment Group | 30M | $28M | 0% | Mar 2024 |
|
Whitebox Advisors | 18M | $16M | 0% | Mar 2024 |
|
Ameriprise Financial | 12M | $11M | -8% | Mar 2024 |
|
Verition Fund Management | 9.5M | $8.9M | 151415% | Mar 2024 |
|
Readystate Asset Management | 8.2M | $7.7M | 0% | Mar 2024 |
|
BlackRock | 1.8M | $1.7M | 0% | Mar 2024 |
|
Kornitzer Capital Management | 600k | $557k | 0% | Mar 2024 |
|
CSS | 445k | $418k | 0% | Mar 2024 |
|
Context Capital Management | 22k | $21M | -100% | Mar 2024 |
|
Who sold out of Ptc Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Linden Advisors | Sep 2023 | 43M | $35B |
Morgan Stanley | Sep 2023 | 3.0M | $2.4M |
Opti Capital Management | Sep 2023 | 3.0M | $2.4M |
Boothbay Fund Management | Sep 2023 | 237k | $189k |